125 related articles for article (PubMed ID: 3123562)
1. Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia.
Chilosi M; Pizzolo G; Semenzato G; Cetto GL
Int J Biol Markers; 1986; 1(2):101-4. PubMed ID: 3123562
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels.
Barak V; Nisman B; Dann EJ; Kalickman I; Ruchlemer R; Bennett MA; Polliack A
Leuk Lymphoma; 1994; 14 Suppl 1():33-9. PubMed ID: 7820051
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
Lauria F; Rondelli D; Raspadori D; Zinzani PL; Benfenati D; Pileri S; Sabattini E; Tura S
Leuk Lymphoma; 1992 May; 7(1-2):103-7. PubMed ID: 1472920
[TBL] [Abstract][Full Text] [Related]
6. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia.
Richards JM; Mick R; Latta JM; Daly K; Ratain MJ; Vardiman JW; Golomb HM
Blood; 1990 Nov; 76(10):1941-5. PubMed ID: 1700727
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V
Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.
Ambrosetti A; Semenzato G; Prior M; Chilosi M; Vinante F; Vincenzi C; Zanotti R; Trentin L; Portuese A; Menestrina F
Br J Haematol; 1989 Oct; 73(2):181-6. PubMed ID: 2818938
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia.
Steis RG; Marcon L; Clark J; Urba W; Longo DL; Nelson DL; Maluish AE
Blood; 1988 May; 71(5):1304-9. PubMed ID: 3129046
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.
Delforge A; Bernier M; Bosmans E; Massy M; Bron D; Heyligen H; Raus J; Mendes Da Costa P; Stryckmans P
Leuk Lymphoma; 1991; 3(5-6):385-93. PubMed ID: 27467429
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia.
Cimino G; Annino L; Giona F; Sgadari C; Di Gregorio AO; Cava MC; Cimino G; Mandelli F
Leukemia; 1991 Jul; 5(7):602-5. PubMed ID: 2072745
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease.
Yasuda N; Lai PK; Ip SH; Kung PC; Hinuma Y; Matsuoka M; Hattori T; Takatsuki K; Purtilo DT
Blood; 1988 Apr; 71(4):1021-6. PubMed ID: 2895675
[TBL] [Abstract][Full Text] [Related]
14. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
[TBL] [Abstract][Full Text] [Related]
15. Hairy cell leukemia in Japanese patients: a study with monoclonal antibodies.
Katayama I; Hirashima K; Maruyama K; Hoshino S; Abe T; Furusawa S; Iguchi Y
Leukemia; 1987 Apr; 1(4):301-5. PubMed ID: 3118108
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
17. Characterization of T-lymphocyte subsets in hairy-cell leukaemia (HCL) by monoclonal antibodies: comparison with Fc gamma, Fc mu receptors and correlation with disease activity.
Lauria F; Foa R; Gobbi M; Pulvirenti A; Raspadori D; Giubellino MC; Tura S
Br J Haematol; 1982 Dec; 52(4):657-62. PubMed ID: 6215933
[TBL] [Abstract][Full Text] [Related]
18. The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors.
Kay NE; Burton J; Wagner D; Nelson DL
Blood; 1988 Aug; 72(2):447-50. PubMed ID: 3135858
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay of mouse interleukin-2 receptors.
Osawa H; Josimovic-Alasevic O; Diamantstein T
J Immunol Methods; 1986 Aug; 92(1):109-15. PubMed ID: 3091697
[TBL] [Abstract][Full Text] [Related]
20. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells.
Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D
Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
